Welcome to our dedicated page for Ingredion SEC filings (Ticker: INGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingredion Incorporated filings document the formal disclosures of a NYSE-listed ingredient solutions company with common stock registered under the ticker INGR. Its 8-K reports include operating results, financial-condition updates, dividend-related corporate actions, leadership changes, board appointments and governance matters.
The company's proxy materials cover director elections, executive compensation, board structure, shareholder voting items and non-management director compensation. Other filings describe capital-structure details for its common stock, exit or disposal activities, impairment charges, restructuring matters and risk disclosures connected to manufacturing operations and the company's plant-based ingredient portfolio.
Ingredion Incorporated plans to cease operations at its Cabo, Brazil manufacturing facility as of June 30, 2026, and expects to sell the facility and underlying real property. The company anticipates approximately $43 million in pre-tax, non-recurring charges tied to this exit plan.
About $36 million of these charges are expected to be non-cash impairment charges related to fixed asset and inventory write-downs, with about $7 million in expected cash expenditures for employee-related, severance, and other termination costs. Most charges are expected in the second quarter of 2026, with remaining amounts through the first quarter of 2027.
Ingredion Incorporated reported weaker first quarter 2026 results, with earnings and operating profit declining year over year and full-year guidance reduced. Net sales were $1.792 billion, down 1% from $1.813 billion in the first quarter 2025 as softer demand and less favorable mix in Food & Industrial Ingredients–U.S./Canada more than offset growth in other segments.
Reported diluted EPS fell to $2.22 from $3.00, while adjusted EPS declined to $2.34 from $2.97, reflecting lower operating income and higher restructuring costs. Reported operating income dropped to $203 million from $276 million, and adjusted operating income decreased to $212 million from $273 million, driven mainly by higher costs and lower volumes in the U.S./Canada business, including production challenges at the Argo facility.
Texture & Healthful Solutions delivered continued volume growth, with operating income of $100 million, slightly above the prior year, and Food & Industrial Ingredients–LATAM posted operating income of $115 million, down from $127 million. All Other generated operating income of $3 million, reflecting improvements in plant-based protein.
The company updated its full-year 2026 outlook, now expecting reported EPS of $9.60–$10.30 and adjusted EPS of $10.45–$11.15. It now anticipates full-year net sales to be flat to up low single digits, reported operating income to be down high single digits, and adjusted operating income to be flat to down low single digits. For full-year 2026, Ingredion expects cash from operations of $725–$825 million and capital expenditures of $400–$440 million.
Ingredion Inc senior vice president David Eric Seip reported a compensation-related grant of phantom stock on April 30, 2026. He acquired 15.63 phantom stock units under the company’s Non-Qualified Deferred Compensation Plan, with each unit representing the right to receive one share of common stock.
Following this grant and prior allocations, Seip now has a total of 13,166.2221 phantom stock units credited under the plan, based on the issuer’s closing share price on April 30, 2026 and including units accumulated through dividend reinvestment.
Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president and chief information officer Michael J. Leonard received a grant of 30.569 phantom stock units on April 30, 2026. These units were credited under the company’s Non-Qualified Deferred Compensation Plan based on the closing price of Ingredion common stock on that date.
Each phantom stock unit represents the right to receive one share of common stock in the future, and the total phantom stock balance for Leonard after this grant is 1,582.171 units, including amounts accumulated through dividend reinvestment.
Ingredion Inc ownership report: Vanguard Capital Management reported beneficial ownership of 3,293,051 shares of Common Stock, representing 5.23% of the class. The filing states Vanguard has sole dispositive power over 3,293,051 shares and sole voting power for 480,686 shares.
The report is a Schedule 13G disclosure by an institutional investor and describes holdings across affiliated Vanguard entities, with signatures executed 04/30/2026.
Ingredion Incorporated reports that First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation jointly reported beneficial ownership of 3,972,425 shares of Common stock, representing 6.31% of the class. The filing states shared voting power of 3,371,328 and shared dispositive power of 3,972,425. The filing is submitted under Rule 13d-1(k)(1) as a joint filing and is signed by James M. Dykas on 04/30/2026.
Ingredion Inc reports that Vanguard Portfolio Management LLC beneficially owned 4,679,559 shares of Common Stock, representing 7.43% of the class as of 03/31/2026. The filing states Vanguard exercises sole dispositive power over 4,679,559 shares and sole voting power for 28,095 shares, and notes ownership is held on behalf of Vanguard funds and managed accounts.
Ingredion Inc director Stephan B. Tanda reported non-market transfers of common stock as bona fide gifts. On April 16, 2026, he reported two gift transactions totaling 760 shares of Ingredion common stock at a reported price of $0.00 per share. One transaction moved 380 directly owned shares to The Tanda Joint Living Trust, where he and his spouse serve as trustees and immediate family members are beneficiaries. After these transactions, 10,737 Ingredion shares are reported as held indirectly through this trust, with no remaining directly held shares shown.
Ingredion Inc director Jorge A. Uribe reported routine charitable-style transfers of company stock. On April 15, 2026, he made two bona fide gifts of Ingredion common shares totaling 624 shares, split into 312 directly owned shares and 312 indirectly held shares.
Following these gifts, Uribe holds 12,924.8574 shares directly and 6,449 shares indirectly through the Cafedan Investments Ltd Trust, where he serves as trustee and his children are beneficiaries. These are non-cash, non-market transactions and do not reflect open-market buying or selling.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president David Eric Seip received a grant of phantom stock under a Non-Qualified Deferred Compensation Plan. The award covers 15.496 phantom stock units based on a reference price of $112.71 per share of common stock.
Following this grant, Seip holds a total of 13,056.1281 phantom stock units. Each phantom stock unit represents the right to receive one share of Ingredion common stock in the future, aligning his compensation more closely with the company’s share performance over time.